SEMPERVIRENS VENTURES LLC

Thesis

SemperVirens Venture Capital is an early-stage venture capital firm founded in 2018, managing approximately $300 million in AUM across its Core Fund III ($141M) and Growth Opportunity Fund II ($36M). The firm focuses on category-defining B2B startups in the health, wealth, and work sectors, with a strong emphasis on AI-driven solutions for employer needs. Their investment thesis targets Healthcare Technology, Workforce/HR Technology, and Financial Services/Fintech, specifically in areas like digital health, virtual care, AI-enabled clinical workflows, talent acquisition, employee benefits, upskilling, employee financial wellness, and fintech adjacent to insurance. SemperVirens primarily invests at the Seed and Series A stages, with follow-on investments from its growth fund. Typical check sizes range from $500,000 to $5 million. A key differentiator is their 'SemperSystem™,' a network of over 200 Fortune 500 advisors, operators, and buyers, used as a go-to-market acceleration engine for enterprise introductions, commercial partnerships, and customer pilots. They actively partner with founders who can utilize this ecosystem. SemperVirens explicitly excludes consumer apps, deep biotech/pre-clinical, and hardware companies without a clear B2B employer-channel strategy. The firm is headquartered in San Mateo, California.

Related lists

• Seed-stage AI investors
• Seed-stage Fintech investors
• Seed-stage Healthcare investors